NCT06993883View on ClinicalTrials.gov

Use of Venetoclax , AML , Sohag , Egypt

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
AML (Acute Myelogenous Leukemia)
Interventions
DRUG

Venetoclax

observational study for the result of venetoclax use combined with chemotherapy in AML patients in Sohag governorate

Trial Locations (1)

82524

Sohag Faculty of Medicine, Sohag

All Listed Sponsors
lead

Sohag University

OTHER